Form 4 NRX Pharmaceuticals Inc: Michael S. Abrams (CFO) For: 28 July
- Form 4 NRX Pharmaceuticals Inc: Michael S. Abrams (CFO) For: 28 July By Investing.com · investing.com · about 11 hours ago
- Form 4 NRX Pharmaceuticals Inc: Jonathan C. Javitt (Director, CEO and Chairman) For: 28 July · investing.com · about 11 hours ago